Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Aranda

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Protocols in Pharmacology|September 21, 2019
Transgenic Tumor Models for Evaluating CAR T-Cell ImmunotherapiesFernando Aranda, Miguel Barajas, Eduardo Huarte
Nature Biomedical Engineering|December 10, 2025
Trispecific engager overcomes tumoural immunosuppressive environmentFernando Aranda, Aline Risson, Pedro Berraondo
Oncoimmunology|July 23, 2014
Myeloid-derived cells are key targets of tumor immunotherapyJosé Medina-Echeverz, Fernando Aranda, Pedro Berraondo
Cancer Discovery|October 2, 2021
Firefighters for the Wrong Type of Inflammation in TumorsIgnacio Melero, Alvaro Teijeira, Fernando Aranda, et al.
Oncoimmunology|December 21, 2023
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosisÁngela Bella, Ignacio Melero, Pedro Berraondo, et al.
Current Opinion in Immunology|June 21, 2014
Impact of myeloid cells on the efficacy of anticancer chemotherapyLaura Senovilla, Fernando Aranda, Lorenzo Galluzzi, et al.
Oncoimmunology|May 6, 2015
Vitamin B6 improves the immunogenicity of cisplatin-induced cell deathFernando Aranda, Norma Bloy, Lorenzo Galluzzi, et al.
Methods in Enzymology|March 18, 2020
Transforming growth factor beta (TGF-β) activity in immuno-oncology studiesGabriel Gallo-Oller, Marianna Di Scala, Fernando Aranda, et al.
Methods in Cell Biology|January 25, 2025
Animal models of disease: Achievements and challengesJosé Manuel Bravo-San Pedro, Fernando Aranda, Aitziber Buqué, et al.
Methods in Cell Biology|March 31, 2024
PrefaceJosé Manuel Bravo-San Pedro, Fernando Aranda, Aitziber Buqué, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Protocols in Pharmacology|September 21, 2019
Transgenic Tumor Models for Evaluating CAR T-Cell ImmunotherapiesFernando Aranda, Miguel Barajas, Eduardo Huarte
Nature Biomedical Engineering|December 10, 2025
Trispecific engager overcomes tumoural immunosuppressive environmentFernando Aranda, Aline Risson, Pedro Berraondo
Oncoimmunology|July 23, 2014
Myeloid-derived cells are key targets of tumor immunotherapyJosé Medina-Echeverz, Fernando Aranda, Pedro Berraondo
Cancer Discovery|October 2, 2021
Firefighters for the Wrong Type of Inflammation in TumorsIgnacio Melero, Alvaro Teijeira, Fernando Aranda, et al.
Oncoimmunology|December 21, 2023
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosisÁngela Bella, Ignacio Melero, Pedro Berraondo, et al.
Current Opinion in Immunology|June 21, 2014
Impact of myeloid cells on the efficacy of anticancer chemotherapyLaura Senovilla, Fernando Aranda, Lorenzo Galluzzi, et al.
Oncoimmunology|May 6, 2015
Vitamin B6 improves the immunogenicity of cisplatin-induced cell deathFernando Aranda, Norma Bloy, Lorenzo Galluzzi, et al.
Methods in Enzymology|March 18, 2020
Transforming growth factor beta (TGF-β) activity in immuno-oncology studiesGabriel Gallo-Oller, Marianna Di Scala, Fernando Aranda, et al.
Methods in Cell Biology|January 25, 2025
Animal models of disease: Achievements and challengesJosé Manuel Bravo-San Pedro, Fernando Aranda, Aitziber Buqué, et al.
Methods in Cell Biology|March 31, 2024
PrefaceJosé Manuel Bravo-San Pedro, Fernando Aranda, Aitziber Buqué, et al.
Pageof 11